Event Information

The UK’s preliminary injunction system is facing mounting pressure. Once seen as a critical tool for protecting rights and preserving the status quo, interim relief is now increasingly viewed as a costly, unpredictable, and procedurally fraught exercise. With high commercial stakes on the line, the legal community is asking: is the system still fit for purpose?

Join us on Wednesday 1 October from 5pm to 8:30pm as we welcome an expert panel of seasoned counsel moderated by Bristows’ partner, Claire Phipps-Jones, to unpack the practical realities of seeking and responding to interim injunctions.

Meet the panellists:

• James Horgan, Chief IP Counsel, Merck Sharp & Dohme (UK) Ltd
• Kristin Cooklin, Global Group Head of IP, Recordati
• Laila Beynon, Director, Dispute Resolution, Regeneron
• Julia Pike, Global Head of IP, Sandoz
• George Moore, Assistant General Counsel, Viatris

Drawing on first-hand experience from the front lines of pharmaceutical and life sciences litigation, they will explore:

• Whether the current legal framework is serving justice or hindering it
• How strategic considerations are evolving in the context of legal uncertainty
• Lessons learnt from recent cases and key procedural hurdles
• Ideas for reform and opportunities to drive change

Whether you’re a litigator or in-house adviser, register now to challenge the status quo and engage in a timely conversation about the future of urgent legal remedies.